These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Darvishian F, Hummer AJ, Thaler HT, Bhargava R, Linkov I, Asher M, Soslow RA. Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675 [Abstract] [Full Text] [Related]
7. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma. Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA. Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767 [Abstract] [Full Text] [Related]
8. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma. Li M, Zhao L, Shen D, Li X, Wang J, Wei L. Chin Med J (Engl); 2014 Dec; 127(8):1459-63. PubMed ID: 24762589 [Abstract] [Full Text] [Related]
9. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Int J Gynecol Pathol; 2004 Apr; 23(2):129-37. PubMed ID: 15084841 [Abstract] [Full Text] [Related]
10. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia]. Taranger-Charpin C, Carpentier S, Dales JP, Garcia S, Djemli A, Andrac L, Lavaut MN, Sferlazzo K, Boubli L. Bull Acad Natl Med; 2004 Apr; 188(3):415-27; discussion 427-9. PubMed ID: 15584653 [Abstract] [Full Text] [Related]
13. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma]. Yao YY, Xu WZ, Wang Y, Shen DH, Wang JL, Wei LH. Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct 18; 43(5):743-8. PubMed ID: 22008688 [Abstract] [Full Text] [Related]
17. Immunoexpression of the PTEN protein and matrix metalloproteinase-2 in endometrial cysts, endometrioid and clear cell ovarian cancer. Brucka A, Szyłło K. Ginekol Pol; 2013 May 18; 84(5):344-51. PubMed ID: 23819399 [Abstract] [Full Text] [Related]
18. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma]. Wang ZQ, Zhang Y, Wang JL, Shen DH, Mu T, Zhao X, Yao YY, Bai Y, Wei LH. Zhonghua Fu Chan Ke Za Zhi; 2012 Jan 18; 47(1):33-9. PubMed ID: 22455691 [Abstract] [Full Text] [Related]
19. Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53. Brunner AH, Riss P, Heinze G, Meltzow E, Brustmann H. Int J Gynecol Pathol; 2011 Nov 18; 30(6):569-75. PubMed ID: 21979593 [Abstract] [Full Text] [Related]
20. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Giordano G, Gnetti L, Merisio C, Melpignano M. Maturitas; 2007 Feb 20; 56(2):190-7. PubMed ID: 16963204 [Abstract] [Full Text] [Related] Page: [Next] [New Search]